Turn Therapeutics Inc. SEC filings TTRX
Turn Therapeutics Inc. has 122 filings in SEC EDGAR's recent list, going back to May 22, 2024. Its latest annual report, Form ARS, was filed on Oct 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Oct 19, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Oct 19, 2026 | Nov 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 7, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| D | Filing | Aug 26, 2026 | — |
| 8-K |
Current report
Unregistered share sale
|
Aug 18, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 17, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 28, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 7, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 1, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2026 | May 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 19, 2026 | May 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 18, 2026 | May 18, 2026 |
| C-TR | Filing | May 13, 2026 | — |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| EFFECT | Filing | Apr 2, 2026 | — |
| EFFECT | Filing | Apr 2, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Mar 31, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Mar 31, 2026 | — |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Mar 24, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 17, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 9, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 7, 2026 | Jan 7, 2026 |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2025 | Nov 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2025 | Oct 30, 2025 |
| 424B5 | Prospectus supplement | Oct 29, 2025 | — |
| 8-K |
Current report
Material agreement
|
Oct 28, 2025 | Oct 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2025 | Oct 22, 2025 |
| S-1 | Registration statement | Oct 9, 2025 | — |
| 424B4 | Prospectus | Oct 8, 2025 | — |
| S-8 | Employee stock plan registration | Oct 7, 2025 | — |
| CERT | Filing | Oct 7, 2025 | — |
| 8-A12B/A | Filing | Oct 7, 2025 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
|
Oct 2, 2025 | Sep 30, 2025 |
| EFFECT | Filing | Sep 30, 2025 | — |
| 8-A12B | Filing | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 26, 2025 | — |
| CORRESP | Letter to the SEC | Sep 24, 2025 | — |
| S-1/A | Amended registration statement | Sep 24, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2025 | — |
| 1-SA | Filing | Sep 22, 2025 | Jun 30, 2025 |
| CORRESP | Letter to the SEC | Sep 16, 2025 | — |
| S-1/A | Amended registration statement | Sep 16, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2025 | — |
| DRS | Filing | Sep 3, 2025 | — |
| S-1 | Registration statement | Sep 2, 2025 | — |
| CORRESP | Letter to the SEC | Aug 29, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2025 | — |
| DRSLTR | Filing | Jul 30, 2025 | — |
| DRS/A | Filing | Jul 30, 2025 | — |
| 1-K | Filing | Jun 27, 2025 | Dec 31, 2024 |
| DRS | Filing | Jun 20, 2025 | — |
| 253G2 | Filing | Jun 13, 2025 | — |
| C-AR | Filing | Apr 29, 2025 | Dec 31, 2024 |
| 253G2 | Filing | Apr 22, 2025 | — |
| 253G2 | Filing | Apr 2, 2025 | — |
| QUALIF | Filing | Mar 31, 2025 | — |
| CORRESP | Letter to the SEC | Mar 27, 2025 | — |
| 1-A/A | Filing | Mar 27, 2025 | — |
| 1-A/A | Filing | Mar 26, 2025 | — |
| CORRESP | Letter to the SEC | Mar 25, 2025 | — |
| 1-A/A | Filing | Mar 25, 2025 | — |
| C-U | Filing | Mar 25, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2025 | — |
| CORRESP | Letter to the SEC | Mar 18, 2025 | — |
| 1-A/A | Filing | Mar 18, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2025 | — |
| CORRESP | Letter to the SEC | Mar 6, 2025 | — |
| 1-A/A | Filing | Mar 6, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 27, 2025 | — |
| 1-A | Filing | Jan 31, 2025 | — |
| C/A | Filing | Jan 17, 2025 | — |
| C/A | Filing | Dec 18, 2024 | — |
| C-U | Filing | Nov 12, 2024 | — |
| C | Filing | Oct 22, 2024 | — |
| C/A | Filing | Aug 19, 2024 | — |
| C/A | Filing | Jul 15, 2024 | — |
| C | Filing | May 22, 2024 | — |
Showing 91 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TTRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westlake Village, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2023016
- Former names
- Global Health Solutions, Inc (until Sep 30, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.